Skip to main content
logo
Aperam S.A. (AMS:APAM)
Netherlands flag Netherlands · Delayed Price · Currency is EUR
25.00
-0.22 (-0.87%)
Aug 6, 2025, 5:35 PM CET

ShockWave Medical Revenue

Aperam had revenue of 1.65B EUR in the quarter ending June 30, 2025, with 1.22% growth. This brings the company's revenue in the last twelve months to 6.28B, down -0.46% year-over-year. In the year 2024, Aperam had annual revenue of 6.26B, down -5.11%.

Revenue (ttm)
6.28B
Revenue Growth
-0.46%
P/S Ratio
0.29
Revenue / Employee
486.51K
Employees
12,007
Market Cap
1.81B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20246.26B-337.00M-5.11%
Dec 31, 20236.59B-1.56B-19.18%
Dec 31, 20228.16B3.05B59.86%
Dec 31, 20215.10B1.48B40.78%
Dec 31, 20203.62B-616.00M-14.53%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
DSM-Firmenich AG13.01B
ArcelorMittal51.63B
Akzo Nobel10.53B
IMCD N.V.4.84B
OCI N.V.941.85M
Corbion1.30B
AMG Critical Materials1.32B
Avantium21.04M
Revenue Rankings

Aperam News

More News